• PDF: Delivered by email usually within 12 to 24 UK business hours.

Genentech, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile

Genentech, Inc. - Pharmaceuticals & Healthcare Deals and Alliances Profile

Genentech, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Genentech, Inc. (Genentech) is a biotechnology company focused on research and development, manufacturing, and marketing of biotherapeutics. Genentech is developing the drugs across the unmet medical needs in cancer, asthma and angiogenic disorders. Major focus of Genentech is on three areas namely; oncology, immunology, and tissue growth and repair. The company is headquartered at South San Francisco in California, Unites States. Genentech is acquired by Roche in March 26, 2009. With this acquisition, the company became the wholly owned subsidiary of the Roche Group.

Global Market Direct's Genentech, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.

Scope

  • Provides key company information for business intelligence needs
  • Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
  • Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

  • A quick ""one-stop-shop"" to understand the company.
  • Support sales activities by understanding your customers' businesses.
  • Qualify prospective partners and suppliers.
  • Understand and respond to your competitors' business structure, strategy and prospects through.
  • Understanding the key deals which have shaped the company.
Table Of Contents Table Of Contents 2 List of Tables 4 List of Figures 5 Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 6 Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 6 Genentech, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 7 Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 8 Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 9 Genentech, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 10 Genentech, Inc., Pharmaceuticals & Healthcare, Deal Details 12 Asset Purchase 12 Genentech Acquires Biologics Manufacturing Facility From Biogen Idec 12 Acquisition 13 Roche Acquires Additional 44.2% Stake In Genentech 13 Genentech Acquires Tanox 14 Genentech Completes Public Offering Of 4.40% Senior Notes For $500 Million 15 Genentech Completes Public Offering Of 4.75% Senior Notes For $1,000 Million 16 Genentech Completes Public Offering Of 5.25% Senior Notes For $500 Million 17 Divestiture - Assets 18 Lonza Acquires Manufacturing Facility From Genentech 18 Equity Offering 19 Tercica Completes Private Placement Of $4 Million 19 Partnerships 20 ImmunoGen Extends Its Licensing Agreement With Genentech 20 Thermo Fisher Scientific Enters Into Co-Development Agreement With Genentech 21 Roche Signs An Agreement With Glycart And Genentech 22 Exelixis Enters Into An Co-Development Agreement With Genentech 23 Abbott Laboratories Enters Into An Agreement With Genentech, OSI And Roche 24 Sangamo BioSciences Expands Agreement With Genentech 25 Tercica Enters Into Collaboration Agreement With Genentech 26 Genentech Enters Into Co-Development Agreement With Abbott 27 Sangamo BioSciences Signs An Agreement With Genentech 28 Seattle Genetics Expands Collaboration Agreement With Genentech 29 Genentech Enters Into Licensing Agreement With Seattle Genetics 30 Exelixis Signs Co-Development Agreement With Genentech 31 Genentech Enters Into Licensing Agreement With CGI Pharmaceuticals 32 Genentech Enters Into Co-Development Agreement With Inotek 33 ImmunoGen Signs An Agreement With Genentech 34 Amgen And Genentech Enter Into A Licensing Agreements For Antibody Patents 35 ImmunoGen Extends Its License Agreement With Genentech 36 Lexicon Enters Into A licensing Agreement With Genentech 37 ImmunoGen Extends Its License Agreement With Genentech 38 Genentech Enters Into An Agreement With Protein Design Labs 39 Exelixis Forms Partnership With Genentech 40 ImmunoGen Renews Its Technology Access Agreement With Genentech 41 ImmunoGen Enters Into Licensing Agreement With Genentech 42 Curis Signs Licensing Agreement With Genentech 43 Curis Signs Co-Development Agreement With Genentech 44 Genentech Amends Its Agreement With OSI Pharmaceuticals 45 Genentech Terminates Agreement With Alkermes 46 Venture Financing 47 HistoRx Secures $1.5 Milliion In Series A Financing 47 Key Competitors 48 Key Employees 48 Locations And Subsidiaries 49 Head Office 49 Other Locations & Subsidiaries 49 Appendix 50 Methodology 50 About Global Markets Direct 50 Contact Us 50 Disclaimer 50 List of Tables Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 6 Genentech, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 7 Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 8 Genentech, Inc., Deals By Sector, 2004 to YTD 2009 9 Genentech, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 10 Genentech Acquires Biologics Manufacturing Facility From Biogen Idec 12 Roche Acquires Additional 44.2% Stake In Genentech 13 Genentech Acquires Tanox 14 Genentech Completes Public Offering Of 4.40% Senior Notes For $500 Million 15 Genentech Completes Public Offering Of 4.75% Senior Notes For $1,000 Million 16 Genentech Completes Public Offering Of 5.25% Senior Notes For $500 Million 17 Lonza Acquires Manufacturing Facility From Genentech 18 Tercica Completes Private Placement Of $4 Million 19 ImmunoGen Extends Its Licensing Agreement With Genentech 20 Thermo Fisher Scientific Enters Into Co-Development Agreement With Genentech 21 Roche Signs An Agreement With Glycart And Genentech 22 Exelixis Enters Into An Co-Development Agreement With Genentech 23 Abbott Laboratories Enters Into An Agreement With Genentech, OSI And Roche 24 Sangamo BioSciences Expands Agreement With Genentech 25 Tercica Enters Into Collaboration Agreement With Genentech 26 Genentech Enters Into Co-Development Agreement With Abbott 27 Sangamo BioSciences Signs An Agreement With Genentech 28 Seattle Genetics Expands Collaboration Agreement With Genentech 29 Genentech Enters Into Licensing Agreement With Seattle Genetics 30 Exelixis Signs Co-Development Agreement With Genentech 31 Genentech Enters Into Licensing Agreement With CGI Pharmaceuticals 32 Genentech Enters Into Co-Development Agreement With Inotek 33 ImmunoGen Signs An Agreement With Genentech 34 Amgen And Genentech Enter Into A Licensing Agreements For Antibody Patents 35 ImmunoGen Extends Its License Agreement With Genentech 36 Lexicon Enters Into A licensing Agreement With Genentech 37 ImmunoGen Extends Its License Agreement With Genentech 38 Genentech Enters Into An Agreement With Protein Design Labs 39 Exelixis Forms Partnership With Genentech 40 ImmunoGen Renews Its Technology Access Agreement With Genentech 41 ImmunoGen Enters Into Licensing Agreement With Genentech 42 Curis Signs Licensing Agreement With Genentech 43 Curis Signs Co-Development Agreement With Genentech 44 Genentech Amends Its Agreement With OSI Pharmaceuticals 45 Genentech Terminates Agreement With Alkermes 46 HistoRx Secures $1.5 Milliion In Series A Financing 47 Genentech, Inc., Key Employees 48 Genentech, Inc., Other Locations 49 List of Figures Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 6 Genentech, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 7 Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 8 Genentech, Inc., Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 9
+44 20 8816 8548

Ask a question about Genentech, Inc. - Pharmaceuticals & Healthcare

Enter the characters you see in the picture below
Captcha